From our previous studies, BMD patients were characterized by reduced and uneven dystrophin expression at the muscle fiber surface, assessed by immunohistochemistry, and a reduced amount of dystrophin with expected, or slightly increased MW, detected by SDS-PAGE and immunoblotting, as reported in the literature [8,9]. The gene discussed is DMD; the disease is Becker muscular dystrophy.